Função pulmonar em indivíduos pós-COVID-19: revisão de escopo
DOI:
https://doi.org/10.34119/bjhrv8n5-154Keywords:
COVID-19, espirometria, SARS-CoV-2, testes de função respiratóriaAbstract
Introdução: A COVID-19 pode ocasionar sequelas respiratórias persistentes, sendo fundamental compreender os impactos na função pulmonar de indivíduos acometidos pela doença. Objetivo: Mapear as evidências científicas sobre os testes de função pulmonar utilizados na avaliação de pacientes pós-COVID-19 e identificar os principais distúrbios ventilatórios encontrados. Método: Revisão de escopo conduzida segundo a metodologia do JBI Collaboration e recomendações do PRISMA-ScR. Foram incluídos estudos com pacientes pós-COVID-19 moderados e graves, ≥18 anos, que realizaram testes de função pulmonar. As buscas foram realizadas nas bases de dados PubMed, LILACS, EMBASE e CINAHL, sem restrição temporal ou de idioma. Resultados: Foram incluídos 13 estudos, totalizando 1373 participantes, entre 18 e 61 anos. A espirometria foi o teste mais utilizado e o principal distúrbio ventilatório identificado foi o restritivo. A maioria dos estudos mostrou que uma proporção significativa de sobreviventes da COVID-19 mantém comprometimento da função pulmonar entre 3 e 12 meses após a alta hospitalar. Conclusão: Pacientes pós-COVID-19, sobretudo os que apresentaram formas moderadas e graves, frequentemente desenvolvem alterações funcionais pulmonares persistentes, destacando-se o distúrbio ventilatório restritivo.
References
ALBU, Sergiu et al. What’s going on following acute covid-19? Clinical characteristics of patients in an out-patient rehabilitation program. NeuroRehabilitation, v. 48, n. 4, p. 469–480, 2021.
BALDINI, Matías et al. Evaluation of the pulmonary function of patients with severe coronavirus 2019 disease three months after diagnosis. Medicina (Buenos Aires), v. 81, n. 5, 2021.
BELLAN, Mattia et al. Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA network open, v. 4, n. 1, p. e2036142–e2036142, 2021.
BOUTELEUX, Benoit et al. Respiratory rehabilitation for Covid-19 related persistent dyspnoea: A one-year experience. Respiratory medicine, v. 189, p. 106648, 2021.
CAVALCANTE, Renata Porangaba; SILVA, Crislayne Maria Acioli Barroso. Sequelas pós Covid - 19 em pacientes em internamento / Post- Covid - 19 sequels in hospitalized patients. Brazilian Journal of Health Review, v. 5, n. 3, p. 10448–10457, 27 maio 2022.
CORTÉS-TELLES, Arturo et al. Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnoea. Respiratory physiology & neurobiology, v. 288, p. 103644, 2021.
DA SILVA, Roseane Maria Ferreira; MELO, Natassy Fragoso. COVID-19: sequelas pós-infecção. Brazilian Journal of Health Review, v. 5, n. 4, p. 13960–13968, 9 ago. 2022.
DA SILVA, Thiago Santos. Comprometimento da função pulmonar em indivíduos pós-COVID-19: um protocolo de revisão de escopo. Disponível em: <https://osf.io/cvyqj/>. Acesso em: 12 dez. 2022.
DARCIS, Gilles et al. Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: a monocentric prospective observational cohort study. International journal of infectious diseases, v. 109, p. 209–216, 2021.
FAVERIO, Paola et al. Six-Month pulmonary impairment after severe COVID-19: a prospective, multicentre follow-up study. Respiration, v. 100, n. 11, p. 1078–1087, 2021.
FONSECA, Ana et al. Avaliação da função pulmonar em pacientes pós-COVID-19-quando e como devemos realizá-la? Jornal Brasileiro de Pneumologia, v. 47, 2021.
FORCE, ARDS Definition Task et al. Acute respiratory distress syndrome. Jama, v. 307, n. 23, p. 2526–2533, 2012.
FUMAGALLI, Alessia et al. Pulmonary function in patients surviving to COVID-19 pneumonia. Infection, v. 49, n. 1, p. 153–157, 28 fev. 2021.
GEORGE, Peter M.; WELLS, Athol U.; JENKINS, R. Gisli. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. The Lancet Respiratory Medicine, v. 8, n. 8, p. 807–815, 2020.
GONZÁLEZ, Jessica et al. Pulmonary function and radiologic features in survivors of critical COVID-19: a 3-month prospective cohort. Chest, v. 160, n. 1, p. 187–198, 2021.
GUO, Tao et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA cardiology, v. 5, n. 7, p. 811–818, 2020.
HELMS, Julie et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive care medicine, v. 46, n. 6, p. 1089–1098, 2020.
LINDAHL, Anna et al. Small airway function in Finnish COVID-19 survivors. Respiratory research, v. 22, n. 1, p. 1–5, 2021.
LIU, Kai et al. Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study. Complementary therapies in clinical practice, v. 39, p. 101166, 2020.
MCDONALD, Lindsay T. Healing after COVID-19: are survivors at risk for pulmonary fibrosis? American Journal of Physiology-Lung Cellular and Molecular Physiology, v. 320, n. 2, p. L257–L265, 2021.
OUZZANI, Mourad et al. Rayyan - a web and mobile app for systematic reviews. Systematic Reviews, v. 5, n. 1, p. 210, 5 dez. 2016.
PAGE, Matthew J. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Systematic reviews, v. 10, n. 1, p. 1–11, mar. 2021.
PETERS, Micah DJ et al. Chapter 11: Scoping reviews. In: AROMATARIS, Edoardo; MUNN, Zachary (Orgs.). JBI Manual for Evidence Synthesis. Adelaide, Austrália: JBI, 2020. v. 169 p. 467–473.
RICHARDSON, Safiya et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. Jama, v. 323, n. 20, p. 2052–2059, 2020.
SALEM, Ayad Mohammed et al. The long-term impact of COVID-19 pneumonia on the pulmonary function of survivors. International journal of general medicine, v. 14, p. 3271, 2021.
SOLANKI, Naisargee et al. Assessment of pulmonary function outcomes in patients with COVID-19 six-weeks post hospital discharge: a single-center observational study in India. Chest, v. 160, n. 4, p. A1753, 2021.
TRICCO, Andrea C. et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Annals of Internal Medicine, v. 169, n. 7, p. 467–473, 2 out. 2018.
WANG, Dawei et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama, v. 323, n. 11, p. 1061–1069, 2020.
ZHOU, Fei et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The lancet, v. 395, n. 10229, p. 1054–1062, 2020.
